Results 171 to 180 of about 1,086,034 (211)

Optimizing Levofloxacin Dosing for Multidrug-resistant Tuberculosis in Low-Fat-Free Mass Asian Populations. [PDF]

Am J Respir Crit Care Med
Liao R, Guo J, Feng Y.
europepmc   +1 more source

Sociodemographic basis of tuberculosis knowledge in Bolivia.

, 2013
Bottomley, Christian, Punchak, Mary, Camacho, Mirtha, Jemio, Carla, McNerney, Ruth, Hernandez, Pilar   +5 more
core   +1 more source

Single Saliva Sample Linezolid Dosing for Multidrug-Resistant Tuberculosis: A Population Pharmacokinetic Modelling of Plasma and Saliva. [PDF]

Clin Pharmacokinet
Nguyen TA, Nguyen TP, Nguyen AT, Dinh LV, Nguyen HB, Vu HD, Nguyen TNB, Vu D, Fox GJ, Alffenaar JC, Stocker SL.   +10 more
europepmc   +1 more source

Incidence and Spatial Mapping of Tuberculosis and Multidrug-Resistant Tuberculosis in Libreville, Republic of Gabon, in 2022. [PDF]

Trop Med Infect Dis
Manzengo C, Ngatu NR, Manguinga-Guitouka S, Lignenguet F, Nkone-Asseko G, Nsimba-Miezi M, Miyatake N, Lami-Nzunzu J, Hirao T.   +8 more
europepmc   +1 more source

Impact of Yuehua Decoction on quality of life and safety in multidrug-resistant tuberculosis: a prospective cohort study using multivariable regression analysis. [PDF]

Front Med (Lausanne)
Sun Q, Huang Q, Mai X, Mo L, Qin Y, Li L, Zeng Y, Liu Q, Liao Y, Liu A.   +9 more
europepmc   +1 more source

Case report from a pediatric multidrug-resistant tuberculosis case with Tsukamurella co-infection identified by whole-genome sequencing: a diagnostic and therapeutic challenge. [PDF]

BMC Infect Dis
Abebaw Y, Ghodousi A, Alemayehu DH, Ayele A, Gebremicael G, Nugusa Y, Asaye G, Diriba G, Getahun M, MaurizioCabibbe A, Abebe M, Sheth A, Argaw R, Abegaz WE.   +13 more
europepmc   +1 more source

Spatial distribution and clustering of multidrug-resistant tuberculosis in Uganda: a nationwide ecological study (2014-2023)

Akello SR, Alunyo JP, Matovu JK, Emetu J, Oposhia J, Ssanyu GN, Bogere MN, Birungi P, Madenje M, Okalebo BC, Okiror W, Paasi G, Nsubuga S, Aujo D, Okibure A, Mukunya D, Olupot-Olupot P.   +16 more
europepmc   +1 more source

Relapse and Emergent Resistance With Novel Short-Course Regimens for Multidrug-Resistant Tuberculosis, United States, 2022-2024. [PDF]

Open Forum Infect Dis
Liang R, Brust JCM, Reed C, Escuyer V, Armstrong DT, Parrish N, Valois P, Rowlinson MC, Marinova-Petkova A, Bisson GP, Labuda SM, Colon-Semidey A, Haley CA, Ashkin D, Peloquin CA, Lardizabal A, Patrawalla A, Cuenca A, Haas MK, Brostrom R, Mbakwem C, Schechter MC, Ray SM, Cummins J, Cahill B, Arn K, Chen LL, Wilson JW, Goswami ND.   +28 more
europepmc   +1 more source

Multidrug-Resistant Tuberculosis in Rural Eastern Cape, South Africa: Clinical, Bacteriological, and Programmatic Predictors of Poor Treatment Outcomes. [PDF]

Microorganisms
Cebisa M, Dlatu N, Hosu MC, Apalata T, Faye LM.   +4 more
europepmc   +1 more source

Spatial autocorrelation and hotspot dynamics of multidrug-resistant tuberculosis in Uganda: a district-level LISA analysis

Akello SR, Alunyo JP, Matovu JK, Emetu J, Mugasha E, Paasi G, Okibure A, Mukunya D, Olupot-Olupot P.   +8 more
europepmc   +1 more source